Cell Growth & Differentiation, Vol 8, Issue 6 699-710, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter

D Spitkovsky, A Schulze, B Boye and P Jansen-Durr
Deutsches Krebsforschungszentrum, Forschungsschwerpunkt Angewandte Tumorvirologie, Heidelberg, Germany.

Treatment of mammalian cells by DNA-damaging agents leads to various cellular responses. At sufficiently high dosage, cisplatin blocks cell proliferation and finally kills cells; this effect is the basis for its widespread use as an anticancer drug. Cisplatin-treated cells arrest in the G1 phase of the cell cycle, most likely due to a signal generated by the stabilization of p53 and the subsequent induction of p21WAF-1/Cip1. We show here that cisplatin-treated mammalian cells accumulate normal levels of cyclin D1 and cyclin E but fail to produce cyclin A. The block to cyclin A gene expression occurs at the level of transcription and is mediated by an E2F binding site in the cyclin A promoter. It is shown here that, upon cisplatin treatment, transcriptionally active free E2F becomes limiting, coincident with the accumulation of hypophosphorylated species of the retinoblastoma protein family. Immunoprecipitation experiments suggest that the loss of free E2F results, at least in part, from the sequestration of E2F-4/DP-1 heterodimers by p107. A role for the kinase inhibitor p21WAF-1/Cip1 in repression of the cyclin A promoter is supported by our finding that ectopic expression of p21WAF-1/Cip1 is sufficient to inhibit transcription from the cyclin A gene, dependent on the E2F site. The data establish the E2F site in the human cyclin A promoter as a key target for the signaling pathway leading to G1 arrest in response to DNA damage by cisplatin and potentially other genotoxic agents.

This article has been cited by other articles:

				M. Minuzzo, M. Ceribelli, M. Pitarque-Marti, S. Borrelli, E. Erba, A. diSilvio, M. D'Incalci, and R. Mantovani Selective Effects of the Anticancer Drug Yondelis (ET-743) on Cell-Cycle Promoters Mol. Pharmacol., November 1, 2005; 68(5): 1496 - 1503. [Abstract] [Full Text] [PDF]

				S. P. Angus, C. N. Mayhew, D. A. Solomon, W. A. Braden, M. P. Markey, Y. Okuno, M. C. Cardoso, D. M. Gilbert, and E. S. Knudsen RB Reversibly Inhibits DNA Replication via Two Temporally Distinct Mechanisms Mol. Cell. Biol., June 15, 2004; 24(12): 5404 - 5420. [Abstract] [Full Text] [PDF]

				A. Mauser, E. Holley-Guthrie, A. Zanation, W. Yarborough, W. Kaufmann, A. Klingelhutz, W. T. Seaman, and S. Kenney The Epstein-Barr Virus Immediate-Early Protein BZLF1 Induces Expression of E2F-1 and Other Proteins Involved in Cell Cycle Progression in Primary Keratinocytes and Gastric Carcinoma Cells J. Virol., November 13, 2002; 76(24): 12543 - 12552. [Abstract] [Full Text] [PDF]

				M. Minuzzo, S. Marchini, M. Broggini, G. Faircloth, M. D'Incalci, and R. Mantovani Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743 PNAS, June 6, 2000; 97(12): 6780 - 6784. [Abstract] [Full Text] [PDF]

				W. H. Park, J. G. Seol, E. S. Kim, J. M. Hyun, C. W. Jung, C. C. Lee, B. K. Kim, and Y. Y. Lee Arsenic Trioxide-mediated Growth Inhibition in MC/CAR Myeloma Cells via Cell Cycle Arrest in Association with Induction of Cyclin-dependent Kinase Inhibitor, p21, and Apoptosis Cancer Res., June 1, 2000; 60(11): 3065 - 3071. [Abstract] [Full Text] [PDF]

				N. Guo, D. V. Faller, and C. Vaziri A Novel DNA Damage Checkpoint Involving Post-transcriptional Regulation of Cyclin A Expression J. Biol. Chem., January 21, 2000; 275(3): 1715 - 1722. [Abstract] [Full Text] [PDF]

				M. Grifman, N. N. Chen, G.-p. Gao, T. Cathomen, J. M. Wilson, and M. D. Weitzman Overexpression of Cyclin A Inhibits Augmentation of Recombinant Adeno-Associated Virus Transduction by the Adenovirus E4orf6 Protein J. Virol., December 1, 1999; 73(12): 10010 - 10019. [Abstract] [Full Text]

				A. Basu, U. Rodeck, G. C. Prendergast, and C. C. Howe Loss of Insulin-like Growth Factor I Receptor-dependent Expression of p107 and Cyclin A in Cells That Lack the Extracellular Matrix Protein Secreted Protein Acidic and Rich in Cysteine Cell Growth Differ., November 1, 1999; 10(11): 721 - 728. [Abstract] [Full Text]

				B. Vogt, K. Zerfaß-Thome, A. Schulze, J. W. Botz, W. Zwerschke, and P. Jansen-Dürr Regulation of cyclin E gene expression by the human papillomavirus type 16 E7 oncoprotein J. Gen. Virol., August 1, 1999; 80(8): 2103 - 2113. [Abstract] [Full Text]

				D Duro, A Schulze, B Vogt, J Bartek, S Mittnacht, and P Jansen-Durr Activation of cyclin A gene expression by the cyclin encoded by human herpesvirus-8 J. Gen. Virol., March 1, 1999; 80(3): 549 - 555. [Abstract]

				A. Schulze, B. Mannhardt, K. Zerfass-Thome, W. Zwerschke, and P. Jansen-Durr Anchorage-Independent Transcription of the Cyclin A Gene Induced by the E7 Oncoprotein of Human Papillomavirus Type 16 J. Virol., March 1, 1998; 72(3): 2323 - 2334. [Abstract] [Full Text] [PDF]

				R.-C. Wu and A. H. Schonthal Activation of p53-p21waf1 Pathway in Response to Disruption of Cell-Matrix Interactions J. Biol. Chem., November 14, 1997; 272(46): 29091 - 29098. [Abstract] [Full Text] [PDF]